Nutralife Biosciences Financials
| NLBS Stock | USD 0.0001 0.00 0.00% |
Nutralife |
Please note, the imprecision that can be found in Nutralife Biosciences' accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Nutralife Biosciences. Check Nutralife Biosciences' Beneish M Score to see the likelihood of Nutralife Biosciences' management manipulating its earnings.
Nutralife Biosciences Stock Summary
NutraLife BioSciences, Inc., together with its subsidiaries, engages in the development, manufacture, and distribution of nutraceutical, dietary, wellness, and cannabidiol products. NutraLife BioSciences, Inc. was incorporated in 2010 and is based in Coconut Creek, Florida. Nutralife Biosciences operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange. It employs 12 people.| Instrument | USA Pink Sheet View All |
| Exchange | PINK Exchange |
| ISIN | US67098B1070 |
| Business Address | 6601 Lyons Road, |
| Sector | Healthcare |
| Industry | Drug Manufacturers—Specialty & Generic |
| Benchmark | Dow Jones Industrial |
| Website | www.nutralifebiosciences.com |
| Phone | 888 509 8901 |
| Currency | USD - US Dollar |
Nutralife Biosciences Key Financial Ratios
There are many critical financial ratios that Nutralife Biosciences' investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that Nutralife Biosciences reports annually and quarterly.Nutralife Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Nutralife Biosciences's current stock value. Our valuation model uses many indicators to compare Nutralife Biosciences value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Nutralife Biosciences competition to find correlations between indicators driving Nutralife Biosciences's intrinsic value. More Info.Nutralife Biosciences is regarded third in return on equity category among its peers. It is regarded second in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Nutralife Biosciences' earnings, one of the primary drivers of an investment's value.Nutralife Biosciences Systematic Risk
Nutralife Biosciences' systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Nutralife Biosciences volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The function did not generate any output. Please change time horizon or modify your input parameters. The output start index for this execution was fourteen with a total number of output elements of fourty-seven. The Beta measures systematic risk based on how returns on Nutralife Biosciences correlated with the market. If Beta is less than 0 Nutralife Biosciences generally moves in the opposite direction as compared to the market. If Nutralife Biosciences Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Nutralife Biosciences is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Nutralife Biosciences is generally in the same direction as the market. If Beta > 1 Nutralife Biosciences moves generally in the same direction as, but more than the movement of the benchmark.
Additional Tools for Nutralife Pink Sheet Analysis
When running Nutralife Biosciences' price analysis, check to measure Nutralife Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Nutralife Biosciences is operating at the current time. Most of Nutralife Biosciences' value examination focuses on studying past and present price action to predict the probability of Nutralife Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Nutralife Biosciences' price. Additionally, you may evaluate how the addition of Nutralife Biosciences to your portfolios can decrease your overall portfolio volatility.